share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director CHAVEZ R. MARTIN

SEC announcement ·  Apr 3 17:44
Summary by Moomoo AI
On April 1, 2024, R. Martin Chavez, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a transaction involving the grant of 2,001 shares of Class A Common Stock at no cost. Following this transaction, Chavez directly holds a total of 60,078 shares in the company. The grant, which is a common form of compensation for executives and employees, reflects the company's practice of aligning the interests of its key personnel with those of shareholders. The transaction was executed under the transaction code 'A', indicating an acquisition of shares.
On April 1, 2024, R. Martin Chavez, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a transaction involving the grant of 2,001 shares of Class A Common Stock at no cost. Following this transaction, Chavez directly holds a total of 60,078 shares in the company. The grant, which is a common form of compensation for executives and employees, reflects the company's practice of aligning the interests of its key personnel with those of shareholders. The transaction was executed under the transaction code 'A', indicating an acquisition of shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more